ArticlePloS one2017

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.

Haneen Banjar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.